ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,378,589, issued on Aug. 5, was assigned to INBIOSE N.V. (Ghent, Belgium).
"In vivo synthesis of sialylated compounds" was invented by Joeri Beauprez (Bredene, Belgium), Pieter Coussement (Gentebrugge, Belgium), Dries Van Herpe (Wondelgem, Belgium), Gert Peters (Ghent, Belgium) and Annelies Vercauteren (Eke, Belgium).
According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure is in the technical field of synthetic biology and metabolic engineering. More particularly, this disclosure is in the technical field of fermentation of metabolically engineered microorganisms. This disclosure describes engineered micro-organisms able to synthesize sialylated comp...